Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/hmg/ddy166 http://scihub22266oqcxt.onion/10.1093/hmg/ddy166 C6048987!6048987!29726992     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Hum+Mol+Genet 2018 ; 27 (15): 2604-13 Nephropedia Template TP {{tp|p=29726992|t=2018. Interaction of AIP with protein kinase A (cAMP-dependent protein kinase) |pdf=|usr=}}{{29726992}} gab.com Text Interaction of AIP with protein kinase A (cAMP-dependent protein kinase) JO: Hum Mol Genet http://www.kidney.de/pget.php?&tw=1&pmid=29726992 #FOAvip Germline mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene cause mostly somatotropinomas and/or prolactinomas in a subset of familial isolated pituitary adenomas (FIPA). AIP has been shown to interact with phosphodiesterases (PDEs) and G proteins, suggesting a link to the cyclic AMP (cAMP)-dependent protein kinase (PKA) pathway. Upregulation of PKA is seen in sporadic somatotropinomas that carry GNAS mutations, and those in Carney complex that are due to PRKAR1A mutations. To elucidate the mechanism of AIP-dependent pituitary tumorigenesis, we studied potential functional and physical interactions of AIP with PKA?s main subunits PRKAR1A (R1?) and PRKACA (C?). We found that AIP physically interacts with both R1? and C?; this interaction is enhanced when all three components are present, but maintained during C?-R1? dissociation by PKA activation, indicating that AIP binds C?/R1? both in complex and separately. The interaction between AIP and R1?/C? is reduced when the frequent AIP pathogenic mutation p.R304* is present. AIP protein levels are regulated both by translation and the ubiquitin/proteasome pathway and C? stabilizes both AIP and R1? protein levels. AIP reduction by siRNA leads to an increase of PKA activity, which is disproportionately enhanced during PDE4-inhibition. We show that AIP interacts with the PKA pathway on multiple levels, including a physical interaction with both the main regulatory (R1?) and catalytic (C?) PKA subunits and a functional interaction with PDE4-dependent PKA activation. These findings provide novel insights on the mechanisms of AIP-dependent pituitary tumorigenesis. Twit Text FOAVip Interaction of AIP with protein kinase A (cAMP-dependent protein kinase) ????Hum Mol Genet http://www.kidney.de/pget.php?&tw=1&pmid=29726992 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29726992 #FOAvip English Wikipedia <ref>{{Cite pmid|29726992}}</ref> Interaction of AIP with protein kinase A (cAMP-dependent protein kinase) #MMPMID29726992 Schernthaner-Reiter MH; Trivellin G; Stratakis CA Hum Mol Genet 2018[Aug]; 27 (15): 2604-13 PMID29726992show ga Germline mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene cause mostly somatotropinomas and/or prolactinomas in a subset of familial isolated pituitary adenomas (FIPA). AIP has been shown to interact with phosphodiesterases (PDEs) and G proteins, suggesting a link to the cyclic AMP (cAMP)-dependent protein kinase (PKA) pathway. Upregulation of PKA is seen in sporadic somatotropinomas that carry GNAS mutations, and those in Carney complex that are due to PRKAR1A mutations. To elucidate the mechanism of AIP-dependent pituitary tumorigenesis, we studied potential functional and physical interactions of AIP with PKA?s main subunits PRKAR1A (R1?) and PRKACA (C?). We found that AIP physically interacts with both R1? and C?; this interaction is enhanced when all three components are present, but maintained during C?-R1? dissociation by PKA activation, indicating that AIP binds C?/R1? both in complex and separately. The interaction between AIP and R1?/C? is reduced when the frequent AIP pathogenic mutation p.R304* is present. AIP protein levels are regulated both by translation and the ubiquitin/proteasome pathway and C? stabilizes both AIP and R1? protein levels. AIP reduction by siRNA leads to an increase of PKA activity, which is disproportionately enhanced during PDE4-inhibition. We show that AIP interacts with the PKA pathway on multiple levels, including a physical interaction with both the main regulatory (R1?) and catalytic (C?) PKA subunits and a functional interaction with PDE4-dependent PKA activation. These findings provide novel insights on the mechanisms of AIP-dependent pituitary tumorigenesis. äInteraction of AIP with protein kinase A (cAMP-dependent protein kinas(epmc).pdf DeepDyve Pubget Overpricing